The objective of this study was to determine the effects of rasagiline as monotherapy on quality of life (QOL) in patients with early Parkinson's disease (PD). Rasagiline, a potent, second-generation, irreversible, selective monoamine oxidase B inhibitor improves PD symptoms in patients with early P
Determinants of quality of life in Brazilian patients with Parkinson's disease
✍ Scribed by Francisco Javier Carod-Artal; Antonio Pedro Vargas; Pablo Martinez-Martin
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 80 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Our objective was to identify determinants of health‐related quality of life (HRQoL) in a cohort of Brazilian patients with Parkinson's disease (PD). Patients were evaluated by means of the Hoehn and Yahr staging (H&Y), Unified Parkinson's Disease Rating Scale (UPDRS), Schwab and England scale (S&E), Mini‐Mental State Exam, Geriatric Depression Scale, and Hospital Anxiety and Depression Scale (HADS). HRQol was assessed using the MOS‐Short‐Form 36 (SF‐36), the Parkinson's disease Questionnaire (PDQ‐39), and the Scales for Outcomes in Parkinson's Disease‐Psychosocial Questionnaire (SCOPA‐PS). 144 patients were evaluated (mean age 62 years; 53.5% men; mean duration of illness 6.6 years; median H&Y, 2 (range: 1–4). Mean SCOPA‐PS and PDQ‐39 Summary Index (SI) were 39.2 and 40.7, respectively. Both, PDQ‐39 and SCOPA‐PS SIs correlated at a moderate level (r = 0.30–0.50) with H&Y, S&E, total UPDRS, HADS subscales, and SF‐36 Physical and Mental Components. PDQ‐39 and SCOPA‐PS were closely associated (r = 0.73). HRQoL significantly deteriorated as H&Y progressed, as a whole. Mood disturbances, disability, motor complications, and education were independent predictors of HRQoL in the multivariate analysis model. In PD Brazilian patients, HRQoL correlated significantly with diverse measures of severity. Depression showed to be the most consistent determinant of HRQoL, followed by disability, motor complications, and education years. There was a close association between the PDQ‐39 and SCOPA‐PS summary scores. © 2007 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract The objective of this study was to evaluate possible relationships between quality of life (QoL) of Polish patients with long‐lasting Parkinson's disease and various demographic and clinical factors. The study comprised 141 patients of Movement Disorders outpatient clinics in Warsaw and
The objective of this study was to examine the quality of life in patients with Parkinson's disease (PD) in a community-based sample (n ס 228 patients) using a Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) as a measure. Associations to the variables age, age at onset, duration, c
## Abstract The impact of Parkinson's disease on quality of life may vary depending on age at onset. We investigated the effect of age at onset on quality of life in a large Parkinson's disease population (n = 426) using a disease‐specific rating scale (PDQ‐39) and with careful adjustment for confo